Taysha Gene Therapies Inc
NASDAQ:TSHA

Watchlist Manager
Taysha Gene Therapies Inc Logo
Taysha Gene Therapies Inc
NASDAQ:TSHA
Watchlist
Price: 2.85 USD -1.38% Market Closed
Market Cap: 584.4m USD

Wall Street
Price Targets

TSHA Price Targets Summary
Taysha Gene Therapies Inc

Wall Street analysts forecast TSHA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TSHA is 6.89 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

Lowest
Price Target
5.05 USD
77% Upside
Average
Price Target
6.89 USD
142% Upside
Highest
Price Target
9.45 USD
232% Upside
Taysha Gene Therapies Inc Competitors:
Price Targets
301047
Sino Biological Inc
25% Upside
ADMA
ADMA Biologics Inc
30% Upside
068270
Celltrion Inc
59% Upside
301207
Hualan Biological Bacterin Inc
18% Upside

Revenue
Forecast

Revenue Estimate
Taysha Gene Therapies Inc

The compound annual growth rate of Taysha Gene Therapies Inc's revenue for the next 3 years is 41%.

N/A
Past Growth
41%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Taysha Gene Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Taysha Gene Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TSHA's stock price target?
Price Target
6.89 USD

According to Wall Street analysts, the average 1-year price target for TSHA is 6.89 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

What is Taysha Gene Therapies Inc's Revenue forecast?
Projected CAGR
41%

The compound annual growth rate of Taysha Gene Therapies Inc's revenue for the next 3 years is 41%.

Back to Top